NVZMF · NOVOZYMES AS/FI
Market Cap
$30.70B
Shares
466.25M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$65.90
Open$66.02
Day$65.15–66.60
52W close$52.10–71.12
Avg vol 30d462
Short int1.2M · 0.3% float · 999+d
Short vol31%
DataJan 2020–Sep 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
0.0%
Trailing year
Short interest
0.3%
Latest settlement · 999+ days to cover
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Limited
Quant / Vol
High
Market backdrop
VIX 15.4 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+7%
above
Price vs 50-day avg
+1%
above
RSI (14)
48
neutral
MACD trend
Negative
52-week position
73%
mid-range
Momentum
relative strength
1-month return
+1%
trailing
6-month return
+5%
trailing
YTD return
+5%
this year
Relative strength
−13%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $65 › 200d $62 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.27% of float · ▼ -20.1% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Squeeze score
58
elevated · 0–100
Fundamentals
Not enough data for a confident read.
Quant / Vol
risk profile
Volatility
49%
annualized · 1-yr
Max drawdown
−31%
past year
ATR
2.6%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+7%
Bullish
Price vs 50-day avg
+1%
Bullish
RSI (14)
48
Neutral
MACD trend
Negative
Bearish
52-week position
73%
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $65 › 200d $62 — 50d above 200d
Institutional flow
Flat
No 13F holder data
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.27% of float · ▼ -20.1% MoM · 1000.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
No 13F holder history
Price context
position in its 52-week range
Range low $52
Now $66 · 73%
Range high $71
vs 200-day avg +7%
vs 50-day avg +1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
NVZMF
this stock
NOVOZYMES AS/FI
|
$30.70B | +5.5% | — | — | 0.3% |
|
LIN
Linde PLC
|
$214.08B | +7.5% | +3.0% | 30.0 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$122.45B | +0.4% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$78.25B | -1.0% | +2.1% | 29.7 | 2.9% |
|
ECL
Ecolab Inc.
|
$76.94B | +3.5% | +2.2% | 36.8 | 1.7% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| NVZMF | -1.5% | +0.8% | +5.2% | -7.3% | +5.5% |
| SPY | +0.6% | -0.8% | +18.2% | -0.6% | +11.8% |
| vs SPY | -2.1% | +1.6% | -13.0% | -6.7% | -6.3% |